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Simultaneous multiple allelic replacement in the malaria
parasite enables dissection of PKG function
Konstantinos Koussis1 , Chrislaine Withers-Martinez1, David A Baker2, Michael J Blackman1,2
Over recent years, a plethora of new genetic tools has trans-
formed conditional engineering of the malaria parasite genome,
allowing functional dissection of essential genes in the asexual
and sexual blood stages that cause pathology or are required for
disease transmission, respectively. Important challenges remain,
including the desirability to complement conditional mutants
with a correctly regulated second gene copy to confirm that
observed phenotypes are due solely to loss of gene function and
to analyse structure–function relationships. To meet this chal-
lenge, here we combine the dimerisable Cre (DiCre) system with
the use of multiple lox sites to simultaneously generate multiple
recombination events of the same gene. We focused on the
Plasmodium falciparum cGMP-dependent protein kinase (PKG),
creating in parallel conditional disruption of the gene plus up to
two allelic replacements. We use the approach to demonstrate
that PKG has no scaffolding or adaptor role in intraerythrocytic
development, acting solely at merozoite egress. We also show
that a phosphorylation-deficient PKG is functionally incompe-
tent. Our method provides valuable new tools for analysis of gene
function in the malaria parasite.
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Introduction
From the early documentation of targeted gene disruption in yeast
by homologous recombination (1) to the use of site-specific
recombinases (2) and the development of gene-editing tools
such as CRISPR (3, 4), the ability to modify DNA has revolutionised
understanding of gene function in model organisms and patho-
gens. Plasmodium spp., the protozoan parasites that are the
aetiological agents of malaria, are responsible for more than
400,000 deaths per year (5), with Plasmodium falciparum causing
the deadliest form of the disease. Widespread resistance to
frontline antimalarial drugs and the absence of an effective vaccine
make the identification of new antimalarial drug targets a necessity
(6), but to achieve this, an improved understanding of the biology of
the parasite is required. Transient transfection of Plasmodium
was first reported almost 3 decades ago (7), but in part due to the
haploid genome of the parasite, functional studies of essential
genes in the asexual blood stages that are responsible for all the
clinical manifestations of the disease have been extremely
difficult.
Conditional deletion or rearrangement of DNA segments through
activation of site-specific recombinases such as Cre has been the
gold-standard system for gene editing in many model organisms,
but attempts to adapt the Cre-lox system to blood stages of P.
falciparum initially failed because of difficulties in suppressing
constitutive activity of the recombinase (8, 9). This problem was
solved with the adaptation of the dimerisable Cre (DiCre) system
initially for Toxoplasma and subsequently for P. falciparum blood
stages (10, 11). In this approach, Cre is expressed in the form of two
enzymatically inactive domains, each of which is fused to a small
rapamycin-binding protein. In the presence of rapamycin (RAP), the
two fusion proteins heterodimerise, rapidly inducing Cre activity (12,
13, 14, 15). The versatility of this system in Plasmodium was sub-
stantially enhanced with the development of the loxPint module,
which elegantly allowed intragenic introduction of “silent” loxP
sites within a small synthetic intron (16). Over the past 5 yr, ad-
ditional modifications have been made to the P. falciparum DiCre
system, including installation of the DiCre cassette into alternative
chromosomal loci and use of different P. falciparum strains, and the
approach has now been exploited for the functional analysis of
many essential genes (17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29). Very
recently, DiCre has been adapted to other Plasmodium species,
including the widely-used rodent malaria model Plasmodium
berghei and the zoonotic pathogen Plasmodium knowlesi (30, 31).
However, application of the system for the simultaneous genera-
tion of both loss-of-function and genetically complemented par-
asite lines has remained technically challenging.
Signalling through cyclic 39,59-guanosine monophosphate
(cGMP) plays important roles in many eukaryotes, including the
malaria parasite. The only known sensor of cGMP signalling in the
parasite is its cGMP-dependent protein kinase (PKG), which is
encoded by a single-copy gene in all Plasmodium species (32, 33).
Chemical genetic and genetic approaches have shown that cGMP
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signalling is essential for key developmental transitions throughout
the entire parasite life cycle, including activation of sexual forms
(gametogenesis), ookinete formation and motility in the mosquito
vector, sporozoite motility and liver cell infection, and maturation
and release (egress) of liver-stage merozoites into the bloodstream
of the vertebrate host (34, 35, 36, 37, 38, 39, 40). In the asexual blood
stages of P. falciparum, the use of highly selective small-molecule
inhibitors of PKG, combined with the use of gatekeeper muta-
genesis to confirm on-target selectivity of the compounds, has
convincingly demonstrated that PKG catalytic activity is not re-
quired during the ~48-h-long period of intraerythrocytic parasite
development (schizogony) but has an essential role in asexual
blood-stage schizont rupture andmerozoite egress (37, 38, 41). More
recently, conditional down-regulation of PKG expression using a
destabilisation domain approach confirmed that the kinase is
required for blood-stage viability; however, in this study, the
specific point(s) in the erythrocytic cycle at which proliferation
arrested was not documented (42). Many kinases and other sig-
nalling proteins operate within multicomponent signalling com-
plexes in which individual members play critical scaffolding or
adaptor roles in addition to any canonical enzymatic roles (43,
44, 45, 46, 47). The various studies alluded to above have clearly
indicated that PKG enzyme activity is not required for intra-
erythrocytic parasite development. However, whether PKG plays
additional scaffolding role(s) throughout intraerythrocytic de-
velopment that may not require catalytic activity is unknown. Many
other aspects of PKG biology are also still unexplored, including the
importance of PKG phosphorylation, a modification that often
plays a role in kinase activation and function (48). Several global
phosphoproteomic studies have identified a total of seven residues
that are phosphorylated in PKG; two of these lie within a cyclic
nucleotide-binding domain and five within the kinase domain (49,
50, 51, 52, 53). Whether phosphorylation of these residues is im-
portant for PKG function has not been examined.
Here, we address these important questions. To enable this, we
describe a modified DiCre system that takes advantage of sto-
chastic Cre-mediated recombination between different lox sites
(54), allowing us to perform in parallel conditional disruption and
allelic replacement of the P. falciparum PKG gene, with the distinct
events indicated by the expression of distinct fluorescent reporter
proteins. Our new system provides valuable new tools for condi-
tional genetics in Plasmodium. Using it, we genetically demonstrate
for the first time that PKG has no essential scaffolding role during
intraerythrocytic malaria parasite development, and we show that a
phosphorylation-deficient form of PKG is nonfunctional.
Results
Introduction of two contiguous lox sites into a short intron to
allow multiple simultaneous conditional gene modifications
We first re-designed the loxPint module (16) to incorporate two
contiguous non-overlapping 34-bp sequences, loxN and lox2272.
These modified lox sites have previously been shown to be in-
compatible with loxP or with each other in different systems (54, 55).
To validate the functionality of the modified loxPint (called 2lox-
Pint) and to assess its capacity to undergo correct splicing, we
inserted the 2loxPint element into the P. falciparum gene encoding
the cGMP-dependent PKG. The P. falciparum PKG gene (pfpkg:
PF3D7_1436600) comprises 4 introns and 5 exons, with all four of its
consensus cyclic nucleotide-binding domains and the kinase do-
main encoded by exons 3–5. Using a Cas9 expression plasmid (19) to
mediate targeted double-stranded DNA cleavage and amarker-free
rescue construct to enable repair by homologous recombination,
we precisely replaced intron 3 of pfpkg with 2loxPint in the DiCre-
expressing P. falciparum B11 line (Fig 1A and B) (25). Limiting dilution
cloning of the modified parasites generated a genetically homogenous
Figure 1. Replacement of pfpkg intron 3 with 2loxPint
allows normal PKG expression and parasite
replication.
(A) Shown is the integrated 2loxPint sequence derived
by nucleotide sequencing of genomic DNA from the
P. falciparum pfpkg_2lox line, aligned with the
expected sequence (both in red). The loxN and lox2272
sites are in grey boxes, with the unique internal AccI
site underlined. Boundaries of the 39 end of exon 3
(AAAG) and the 59 end of exon 4 (GGT) are shown in
black. (B) Schematic representation of the strategy
used to replace intron 3 of the pfpkg gene with 2loxPint
in the DiCre-expressing B11 P. falciparum line.
Positions of oligonucleotides used for diagnostic
PCR are indicated (red and blue arrows). (C) (Left)
Diagnostic PCR results showing absence of the
endogenous intron 3 in the pfpkg_2lox line (2lox)
relative to the parental B11 line (wt). (Right)
Diagnostic PCR results and restriction digest of the
PCR amplicon with AccI, showing the expected
digestion only of the amplicon from the pfpkg_2lox
line (2lox). (D) Western blot analysis of extracts of wt
and pfpkg_2lox schizonts, showing similar
expression levels of PKG (~98 kD, indicated).
Antibodies to the cytoplasmic parasite protein HSP70
were used as a loading control. (E) Growth curves
showing replication of DMSO-treated (control) or RAP-treated pfpkg_2lox parasites relative to the parental line B11. Mean values are shown from triplicate
experiments. Error bars ± SD (n = 3).
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parasite line called pfpkg_2lox. Correct integration of the 2loxPint
intron into the pfpkg locus of these parasites was verified by
diagnostic PCR and confirmed by restriction digest analysis and
Sanger sequencing of the PCR amplicon (Fig 1B and C). Western
blot analysis with a polyclonal anti-PKG antibody confirmed that
levels of PKG expression in pfpkg_2lox schizonts were indistin-
guishable from those of the parental B11 line (Fig 1D). To assess
whether the 2loxPint modification could affect parasite fitness or
lead to undesirable gene disruption by DiCre-mediated recom-
bination within the intron (which was not expected given the
incompatibility of the loxN and lox2272 sites), replication of the
pfpkg_2lox parasites was monitored after treatment with RAP or
vehicle only (DMSO control). This confirmed in both cases normal
growth rates relative to the parental B11 line (Fig 1E). Collectively,
these results showed that replacement of the endogenous pfpkg
intron 3 with 2loxPint produced no detectable defect in PKG ex-
pression or parasite growth, in turn indicating efficient splicing of
the 2loxPint intron.
An allelic replacement approach for simultaneous disruption and
complementation of the pfpkg gene
Having established the pfpkg_2lox parasite line, we next further
genetically modified the parasites to enable simultaneous dis-
ruption and replacement of the pfpkg gene, using the paired,
mutually incompatible lox sites within the 2loxPint intron. To do
this, we once again used a marker-free Cas9-mediated strategy to
adapt the 39 flanking sequence of the pfpkg locus (Fig 2A). Addi-
tional loxN and lox2272 sites were introduced, positioned within
intervening sequences such that DiCre-mediated recombination
between the two loxN sites (one within the 2loxPint and one
downstream of the pfpkg ORF) was expected to reconstitute se-
quence encoding a full-length PKG fused to the fluorescent protein
eGFP. In contrast, recombination between the two lox2272 sites
would instead severely truncate the endogenous PKG gene, si-
multaneously fusing the residual N-terminal 92 residues of the
protein to mCherry. We reasoned that use of the two fluorescent
reporter proteins in this way would facilitate microscopic detection
of the expected recombination events after induction of DiCre
activity (35, 56).
Correct integration of the 39 targeting construct was confirmed by
PCR (Fig S1A) and a clonal parasite line was obtained by limiting
dilution. As expected, transient RAP treatment of this line, termed
pkg:wGFP-ckoR, resulted in the generation of eGFP and mCherry-
expressing parasites, corresponding to recombination between
either the two loxN sites, leading to a perfect allelic replacement
(PKGsynth_GFP), or between the two lox2272 sites, resulting in
disruption of the pfpkg gene and expression of mCherry
(ΔPKG_mCherry). The expected recombination events were de-
tectable by diagnostic PCR (Fig 2B), and expression of the predicted
fusion proteins in RAP-treated parasite cultures was confirmed by
Western blot using antibodies to GFP and mCherry (Fig 2C).
Quantitation by flow cytometry and live microscopy of the eGFP and
mCherry-positive parasites at the end of the erythrocytic cycle of
RAP treatment (henceforth referred to as cycle 0) indicated that
these were formed at a ratio of ~9:1 (Fig 2D), suggesting that re-
combination between the loxN sites was substantially favoured,
probably as a result of the relatively short distance between these
sites in the modified pkg:wGFP-ckoR genome (Fig 2A). Collectively,
these results confirmed that simultaneous generation of two ge-
netically distinct populations within a single erythrocytic cycle after
RAP treatment is achievable in P. falciparum.
PKG has no scaffolding role during intraerythrocytic parasite
development
Previous chemical genetic studies on asexual blood-stage P.
falciparum have shown that selective inhibition of PKG activity
prevents discharge of specialised secretory organelles called
micronemes and exonemes, with a resulting block in egress (38).
However, whether PKG expression plays a non-enzymatic role
throughout the erythrocytic life cycle has not been addressed
genetically.
The generation in a single step of readily distinguishable pop-
ulations of PKGsynth_GFP (expected to be phenotypically wild type)
and ΔPKG_mCherry (PKG-null) parasites allowed us to now examine
the effects of PKG disruption or reconstitution on the entire asexual
blood-stage life cycle under identical conditions. To do this, we first
examined replication of control (DMSO-treated) and RAP-treated
pkg:wGFP-ckoR parasites over the course of three erythrocytic
cycles (~72 h). Because of the high proportion of PKGsynth_GFP
parasites in the RAP-treated cultures, we expected to see only very
small differences in overall replication rates in the cultures over
this period, a prediction that was confirmed experimentally (Fig 3A).
However, examination of the RAP-treated cultures revealed com-
plete loss of the mCherry-expressing ΔPKG_mCherry parasites by
the end of cycle 1, suggesting a severe growth defect upon PKG
disruption (Fig 3B). To analyse this defect in more detail over the
course of a single erythrocytic cycle, a highly synchronous culture
containing ring-stage pkg:wGFP-ckoR parasites (parasitaemia
~6.5%) was RAP-treated and then incubated for a further 40 h to
allow development to mature schizont stage, the point in the
lifecycle at which PKG expression peaks (57). Microscopic exami-
nation over the course of this period revealed the appearance of
both eGFP-expressing andmCherry-expressing mature schizonts as
expected, with no decrease in total parasitaemia relative to that at
the start of that cycle. This showed that all or most RAP-treated
parasites were able tomature normally over the course of cycle 0, in
turn indicating that ablation of PKG expression does not affect
subsequent intraerythrocytic maturation within that cycle. Samples
of the culture were then assessed by flow cytometry at intervals
over the ensuing 3 h. As shown in Fig 3C, this revealed a gradual
time-dependent decrease in the proportion of PKGsynth_GFP
schizonts, presumably due to rupture of these parasites as they
reached full maturity and underwent merozoite egress. In contrast,
the total proportion of ΔPKG_mCherry parasites gradually in-
creased over the 3-h period, suggesting a selective defect in rupture
as mature schizonts accumulated. To further quantify this under
conditions where the schizonts made up a greater proportion of the
total cell population, we enriched mature cycle 0 schizonts from
similar cultures and again used flow cytometry to selectively ex-
amine time-dependent changes in the proportions of fluorescent
cells in the enriched schizont population. This revealed a greater
than twofold increase over a 3-h period in the proportion of
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ΔPKG_mCherry parasites in the schizont population (Figs 3D and
S2), whereas the proportion of PKGsynth_GFP schizonts again
decreased. This further supports a selective arrest in egress in the
ΔPKG_mCherry mutants.
To finally examine the phenotype of PKG disruptionmore closely,
we used time-lapse video microscopy to visualise parasite fate at
egress. For this, mature schizonts enriched from RAP-treated pkg:
wGFP-ckoR cultures were further incubated for 3 h in the presence
of the reversible PKG inhibitor 4-[7-[(dimethylamino)methyl]-2-(4-
fluorphenyl)imidazo[1,2-α]pyridine-3-yl]pyrimidin-2-amine (com-
pound 2). This prevents egress while allowing schizonts to reach full
maturation, effectively synchronising the schizonts at a state of
high maturation. Removal of compound 2 from wild-type parasites
leads to PKG activation and schizont rupture within minutes, which
can be monitored microscopically. As shown in Fig 3E and Video 1,
this showed that only the PKGsynth_GFP parasites underwent
egress, whereas the ΔPKG_mCherry parasites displayed no signs of
parasitophorous vacuole rupture or any of the other morphological
changes that generally precede egress (26, 58, 59, 60), remaining
trapped inside their host red blood cells. Taken together, these
results convincingly demonstrate that PKG has no detectable non-
catalytic scaffolding role during maturation of asexual blood-stage
Figure 2. Stochastic recombination between
multiple lox sites creates genetically distinct
parasite populations within a single culture.
(A) Schematic of the Cas9-enhanced targeted
homologous recombination approach used to create
the pkg:wGFP-ckoR line. Positions of the four
consensus cyclic nucleotide-binding domains (CNA-
CND) and the catalytic domain (open red box) of PKG
are shown. The position targeted by the guide RNA
used to direct Cas9-mediated cleavage is indicated
(blue line), as are positions of the loxN (yellow
arrowheads) and lox2272 (green arrowheads) sites.
RAP-induced DiCre activity switches expression from wt
PKG to either a gene replacement with a partially
synthetic pfpkg gene fused to eGFP (recombination
event 1; PKGsynth_GFP) or to gene disruption and
expression of a truncated protein lacking the cyclic
nucleotide-binding and kinase domains, fused to
mCherry (recombination event 2; ΔPKG_mCherry). Black
arrows; oligonucleotide primers used for
identification of both events by diagnostic PCR. Note
that tagging of PKGwith a C-terminal eGFP was expected
to be tolerated because it has previously been
achieved in the rodent malaria model P. berghei (29).
(B) Diagnostic PCR showing generation of products
corresponding to both predicted recombination
events upon amplification from genomic DNA of RAP-
treated pkg:wGFP-ckoR parasites. Expected sizes of the
amplicons corresponding to PKGsynth_GFP and
ΔPKG_mCherry are 5.6 and 1.3 kb, respectively. Multiple
attempts to amplify the corresponding region from
mock-treated parasites (−RAP) failed, probably
because of the large size of the predicted amplicon
(~10 kb). (C) Western blot showing loss of expression of
PKG upon RAP treatment of pkg:wGFP-ckoR
parasites, concomitant with appearance of signals
corresponding to the PKG_GFP fusion (expected
molecular mass 125 kD) and the mCherry fusion
(expected mass 38 kD; red asterisk). After being probed
with rabbit anti-PKG antibodies (left-hand blot), the
membrane was re-probedwith a rabbit anti-mCherry
antibody to demonstrate the appearance of mCherry
only in the RAP-treated sample and to highlight the
difference between the DMSO- and the RAP-treated
samples for both PKG (black asterisk) and mCherry.
Note that the PKG_GFP fusion is not recognised by the
commercially available PKG antibody because of
masking of the C-terminal epitope, as previously
observed (57). (D) (Left) Quantification by flow cytometry
of the relative proportions of PKGsynth_GFP and
ΔPKG_mCherry parasites in RAP-treated pkg:wGFP-
ckoR parasites (sampled at the end of cycle 0).
Individual values (dark circles or squares) are shown
from five biological replicate experiments (n = 5), and mean values are indicated as bars. Statistical significance was determined by unpaired t test (P-value < 0.0001).
(Right) Representative image from differential inference contrast/fluorescence microscopic examination of RAP-treated pkg:wGFP-ckoR parasites (end of cycle 0),
showing both GPF- and mCherry-positive schizonts. Scale bar, 10 μm.
Simultaneous gene disruption and replacement in Plasmodium Koussis et al. https://doi.org/10.26508/lsa.201900626 vol 3 | no 4 | e201900626 4 of 14
Figure 3. PKG-null parasites undergo normal intraerythrocytic development but arrested egress.
(A) Growth curves showing replication of DMSO-treated (control) or RAP-treated pkg:wGFP-ckoR and pfpkg_2lox parasites. Percentage parasitaemia values are shown
(quantified by flow cytometry). Error bars ± SD (n = 3). (B) Differential inference contrast/fluorescence images of schizonts from a RAP-treated pkg:wGFP-ckoR culture,
showing virtual disappearance of ΔPKG_mCherry parasites by the end of cycle 1. (C) Two-parameter dot plot representation of flow cytometry data monitoring the relative
proportions of PKGsynth_GFP schizonts (green box, Q3; lower right-hand quadrant) and ΔPKG_mCherry schizonts (red box, Q1; upper left-hand quadrant) with time.
Monitoring was initiated ~44 h after RAP treatment of a highly synchronous pkg:wGFP-ckoRc culture. The percentage of each population at each time point is shown within
the relevant quadrant. The Q4 population predominantly represents uninfected erythrocytes. Parasitaemia at the point of RAP-treatment (the start of cycle 0) was 6.5%.
(D) Histogram depiction of flow cytometry analysis of schizonts enriched ~44 h after RAP treatment of a pkg:wGFP-ckoRc culture, showing time-dependent accumulation of
ΔPKG_mCherry schizonts and loss of PKGsynth_GFP schizonts over a 3-h time period. (E) Stills from time-lapse differential inference contrast/fluorescencemicroscopy of
isolated, RAP-treated pkg:wGFP-ckoR schizonts after release of a compound 2–mediated egress block, showing that only the PKGsynth_GFP schizonts undergo rupture and
merozoite egress. No rupture of the ΔPKG_mCherry schizonts was observed even after prolonged imaging. Scale bars, 10 μm.
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schizonts, while confirming that it is essential for schizont rupture
and merozoite egress.
Removal of phosphosites renders PKG nonfunctional
Previous studies of the Cre-lox system in other organisms have
demonstrated that the efficiency of Cre-mediated site-specific
recombination generally decreases as a function of the linear
“distance” between chromosomal loxP sites (61). In the pkg:wGFP-
ckoR line, the genetic distance between the loxN and lox2272 re-
combination events was 3.6 and 7.7 kb, respectively. We reasoned
that thismore than twofold difference was likely responsible for the
relatively inefficient generation of the ΔPKG_mCherry parasites (the
lox2272 recombination event; Fig 2A). To examine whether we could
obtain more similar ratios of the two recombination events, fa-
cilitating comparative analysis of the resulting genetically distinct
populations, we designed a modified strategy in which recombi-
nation between the more closely situated lox sites would result in
gene disruption, whereas recombination between the pair of more
spatially distant lox sites would lead to allelic replacement.
To test and validate this system, we focused on the importance of
the known phosphorylation sites within P. falciparum PKG. A total of
seven phosphosites (Fig 4A) have previously been identified
through several independent phosphoproteome studies by dif-
ferent groups (49, 50, 51, 52, 53). To examine the essentiality of
phosphorylation at these sites, we decided to compare the phe-
notype resulting from PKG disruption with that resulting from allelic
replacement with a mutant form of PKG in which the seven Ser, Thr,
or Tyr residues that are targets of phosphorylation were replaced
with Ala residues.
Repair construct pDC_loxNmCherry:lox22PKG (Fig S1B) was in-
troduced into pfpkg_2lox parasites and, after limiting the dilution
cloning, correct modification by homologous recombination of the
modified pfpkg locus was confirmed by PCR. RAP treatment of the
resulting parasite line, called pkg:ckoR-mutGFP, resulted in the
expected recombination events as determined by diagnostic PCR
(Fig 4B and C). As predicted given the more similar distances
between the compatible lox sites in this parasite line, ratios of
GFP and mCherry-positive schizonts at the end of cycle 0 were
roughly comparable, demonstrating efficient generation of both
ΔPKG_mCherry and PKGmut_GFP transgenic parasites in the same
culture after a single RAP treatment (Fig 4D). Also as expected, the
mature schizonts that appeared at the end of cycle 0 in the RAP-
treated cultures were morphologically indistinguishable from
those in control, DMSO-treated cultures, further indicating normal
intracellular development in all the fluorescent parasites despite
the fact that approximately half of the RAP-treated culture lacked
expression of full-length PKG (Fig 4E), whereas the other half
expressed the PKGmut_GFP mutant in which all seven phosphor-
ylated residues were substituted with Ala residues.
To investigate the long-term viability of these parasites, RAP-
treated or DMSO-treated pkg:ckoR-mutGFP cultures were moni-
tored in parallel for three erythrocytic cycles. A complete arrest of
parasite proliferation was observed in the RAP-treated cultures (Fig
4F). To compare the egress phenotype of the PKGmut_GFP parasites
with that of the ΔPKG_mCherry parasites, we again used time-lapse
microscopy to monitor egress, using as controls schizonts of the
parental pkg:ckoR-mutGFP line. As shown in Fig 4G and Video 2, the
PKGmut_GFP schizonts displayed an egress defect identical to that
of the ΔPKG_mCherry parasites. To corroborate these findings, we
monitored the appearance in culture supernatants of SERA5, an
abundant parasitophorous vacuole protein which is released into
culture supernatants upon egress (38, 62). As shown in Fig 4H,
processed SERA5 was completely absent from culture supernatants
of the RAP-treated pkg:ckoR-mutGFP schizonts. These experiments
clearly showed that Ala substitution of its seven known phos-
phosites renders PKG functionally inactive, producing a phenotype
that mimics conditional disruption of the pfpkg gene.
Expanding the DiCre toolkit with the introduction of the 3loxPint
module
To unambiguously rule out a non-catalytic role for PKG during
intraerythrocytic parasite growth and to expand the utility of our
new toolbox for simultaneous creation of multiple allelic re-
placements, we examined whether it was possible to introduce a
third different lox sequence into the loxPint intron to allow a third
potential outcome after induction of DiCre activity. For this, we
added a lox71 site to the 2loxPint, creating module 3loxPint (Fig S3A
and B). Cre-mediated recombination between lox71 and the lox66
site creates a unique lox72-mutant site, which is also incompatible
with loxP (25, 63). As previously, we first precisely replaced the
endogenous intron 3 of pfpkg in the P. falciparum B11 line with the
3loxPint module. A clonal modified parasite line was obtained
(called pfpkg_3lox) and the modification verified by diagnostic PCR,
restriction digest analysis, and nucleotide sequencing (Fig S3B and
C). Western blot analysis of pfpkg_3lox schizonts with PKG-specific
antibodies showed no differences in PKG expression levels be-
tween this line, pfpkg_2lox and parental B11 parasites (Fig S3D),
indicating correct splicing of the 3loxPint.
To enable detection of individual recombination events, we
decided as previously to design downstream modifications of the
modified pfpkg_3lox gene such that each distinct recombination
event would lead to expression of a different fluorescent protein. To
validate the system and to further examine the effects of pfpkg
disruption, we decided to design the system such that all three
recombination events would lead to conditional truncation of
pfpkg (Fig 5A), enabling us to follow maturation of these parasites
under conditions in which essentially the entire culture comprised
PKG-null parasites. To do this, pfpkg_3lox schizonts were trans-
fected with repair construct plasmid pDC_3cKO and clonal line pkg:
3cko obtained (Fig S1C). Synchronous ring-stage cultures of pkg:
3cko were then treated with RAP and the resulting cycle 0 schizont-
stage parasites were examined by diagnostic PCR using distinct
primers designed to detect each predicted potential outcome of
recombination between the various lox sites. All three expected
recombination events were confirmed (Figs 5B and S4), supported
by fluorescence microscopy examination which showed the
presence of schizonts expressing mTagBFP2, eGFP, or mCherry (Fig
5C). Differential counts showed that these parasites were present in
the population at proportions of 11.8% ± 1.98%, 81.6% ± 3.2%, and
6.6% ± 1.2%, respectively (n = 2), indicating a strong preference for
recombination between the loxN sites. This latter result also
confirmed correct splicing of all versions of the modified intron
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Figure 4. Phosphosite mutations render P. falciparum PKG inactive.
(A) Cartoon of the P. falciparum PKG x-ray crystal structure (PDB ID: 5DYK) in its apo form with rainbow colouring (N terminus in dark blue; C terminus in red). Cyclic
nucleotide-binding domains A (dark blue), B (cyan), C (green), and D (lime) are shown, whereas the central kinase domains are in yellow/orange/red. Phosphosites
identified by mass spectrometry are indicated and shown as sticks within colour-matching transparent spheres. The image was ray-traced in the PyMOL Open-Source
Molecular Graphic System (https://pymol.org/2/). (B) Schematic of the modified pfpkg locus in the pkg:cKOR-mutGFP parasite line. Upon DiCre induction with RAP,
recombination event 1 leads to conditional gene disruption (ΔPKG_mCherry), whilst recombination event 2 leads to replacement of the endogenous allele with a partially
synthetic full-length allele containing Ala substitutions of all seven phosphosites (asterisks), fused to GFP (recombination event 2; PKGmut_GFP). (C) Diagnostic PCR results
showing detection of the two distinct recombination events after DiCre activation. The amplicon specific for ΔPKG_mCherry (denoted by the black and red arrows) is ~1
kb in the RAP-treated sample and ~4.9 kb in the mock-treated (non-excised) sample. The amplicon specific for PKGmut_GFP is ~4 kb in the RAP-treated sample.
Amplification frommock-treated samples was unsuccessful, likely because of the large size of the predicted fragment. (D)Quantification of the ratio between PKGmut_GFP
and ΔPKG_mCherry schizonts in the RAP-treated parasite population at the end of cycle 0. Data shown are from five independent experiments; individual and mean
values are shown. Error bars ± SD (n = 5). (E) Giemsa-stained images of Percoll-enriched schizonts isolated at the end of cycle 0 of DMSO- and RAP-treated pkg:cKOR-
mutGFP parasites, showing no discernible morphological differences. Scale bar, 10 μM. (F) Replication of DMSO- and RAP- treated pkg:ckoR_mutGFP parasites over three
erythrocytic cycles. Parasitaemia values shown (obtained by flow cytometry) are averages of three independent experiments. Error bars ± SD (n = 3). (G) Both
PKGmut_GFP and ΔPKG_mCherry schizonts are defective in egress. Still images of the first and final frame of a 30-min time-lapse video of mock-treated (grey) or RAP-
treated (green and red) pkg:ckoR_mutGFP parasites. Schizonts were synchronised by incubation with the reversible PKG inhibitor compound 2, then washed, mixed in
equal proportions, and monitored for egress over a period of 30 min. Neither the red (ΔPKG_mCherry) nor the green (PKGmut_GFP) schizonts underwent egress,
whereas most of the parental mock-treated pkg:ckoR_mutGFP schizonts ruptured. Scale bar, 10 μΜ. (H)Western blot showing that no SERA5 P50 was released into culture
supernatants of RAP-treated pkg:ckoR_mutGFP schizonts, consistent with impaired egress in both the PKGmut_GFP and ΔPKG_mCherry schizonts.
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after recombination. Importantly, there was no reduction in par-
asitaemia over the course of cycle 0 despite the high levels of
fluorescent parasites at schizont stage, proving that disruption of
PKG had no effect on intraerythrocytic parasite development. Com-
parison of pfpkg_3lox and pkg:3cKO parasite replication over ensuing
cycles showed that RAP treatment of pkg:3cKO parasites led to a
complete arrest in parasite growth (Fig 5D), as expected.
Discussion
The use of site-specific recombinases and mutually incompatible
lox sites has been a powerful tool for conditional mutagenesis and
gene expression in many organisms, with a notable example being
multicolor labelling of tissues for the study of neuronal and de-
velopmental circuits in metazoa (54, 64, 65, 66). Here, we have
effectively adapted this principle for use in the malaria parasite to
address key challenges in Plasmodium genetics and to gain crucial
new insights into the role of PKG in parasite blood-stage devel-
opment. By introducing two or three distinct lox sites into an ar-
tificial Plasmodium intron we have been able for the first time to
analyse simultaneously up to three distinct allelic replacements of
PKG, allowing us to demonstrate that PKG has no essential scaf-
folding role during intraerythrocytic development and to geneti-
cally confirm its essentiality for egress. This is despite the fact that
PKG has been shown to be expressed in asexual stages as early as
24 h post invasion, with levels of expression reaching a maximum in
late schizogony (57).
Figure 5. Simultaneous generation of three distinct allelic exchange events.
(A) Schematic of the approach used to conditionally disrupt pfpkg and create three distinct knockout parasite populations expressing either mTagBFP2 (ΔPKG_BFP2),
eGFP (ΔPKG_GFP), or mCherry (ΔPKG_mCherry). Positions of lox sites are indicated with coloured arrowheads (yellow, loxN; green, lox2272; purple, lox71; brown, lox66).
Positions of oligonucleotide primers used for diagnostic PCR are indicated (coloured arrows). (B) Confirmation by diagnostic PCR of the three recombination events (RE1,
RE2, and RE3, respectively) in RAP-treated pkg:3cKO parasites. Coloured arrows represent identify of the primers used. (C) Growth assay of the pfpkg_3lox and pkg:3cKO
parasite lines after mock-treatment (DMSO) or treatment with RAP. Parasitaemia was measured by flow cytometry. Error bars ± SD (n = 6). (D) Fluorescent microcopy
images of live RAP-treated pkg:3cKO schizonts from the end of cycle 0, confirming the presence of all three fluorescent populations. Scale bars, 10 μΜ.
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Genetic complementation of Plasmodium knockouts with either
a wild-type second copy of the gene to rescue the observed
phenotype or amutant copy to examine the role of specific residues
or domains can be challenging. Episomal complementation, al-
though technically simple and the method of choice in cases where
multiple mutants need to be screened (e.g., (67)), can sometimes be
partially successful because of poor segregation of plasmids in
Plasmodium, leading to highly variable levels of expression in
individual parasites and the need to maintain transgenic parasite
populations under selective drug pressure (68, 69). Complemen-
tation by integration into a nonessential locus is preferable but
again full restoration of the phenotype is not always possible
because constitutive expression of a second gene copy can affect
parasite fitness or correct trafficking of the gene product (26, 70, 71,
72). Complementation studies in animal models of malaria require
extensive use of animals or the creation of mutants from inde-
pendent transfections (73). The preferred method of choice is to
insert a complementing allele into the authentic endogenous locus
so that expression is driven by the native promoter, as described
here with our new system.
The importance of genetic distance between Cre-mediated re-
combination events has been previously documented in other sys-
tems (61) and was also evident in our data. Experiments in ES cells
and mice have revealed three important parameters in site-specific
recombination: a) levels of Cre expression (which in our study should
be the same in all parasites); b) the genetic distance between lox
sites; and c) the nature of the DNA sequence (74). In parallel, studies
of two distinct mutants of a gene of interest, an unequal ratio of the
different recombination events is therefore to be expected, especially
in the case of larger genes. This could limit the utility of the 3loxPint
system. In addition, our 3loxPint results suggested a preference for
recombination between loxN sites as compared with recombination
between lox2272 or lox71/lox66 pairs. Multiple site–specific recom-
bination is to our knowledge, a largely unexplored area in Plasmo-
dium. It would be interesting in future experiments to study the
impact of different lox sites on recombination ratios.
The new loxPint modules described here represent useful ad-
ditions to the expanding toolkit (75, 76, 77, 78, 79) for conditional
Plasmodium genetic modification, allowing up to three modifica-
tions of a gene of interest to be studied in parallel. The use of
fluorescent markers combined with flow cytometry can also fa-
cilitate enrichment of the resulting parasite populations, which can
be used subsequently for biochemical or phenotypical studies
more readily than by generating and analysing independent lines.
The system has allowed us to improve understanding of the role of
PKG in blood-stage egress, providing an exciting background for
further investigation of the function of this essential enzyme and its
potential as a drug target.
Materials and Methods
Reagents and antibodies
The antifolate drug WR99210 was from Jacobus Pharmaceuticals.
Rapamycin was from Sigma-Aldrich and used to treat parasites at 20
nM. The PKG inhibitor (4-[7-[(dimethylamino)methyl]-2-(4-fluorphenyl)
imidazo[1,2-α]pyridine-3-yl]pyrimidin-2-amine) (compound
2) was stored at −20°C as a 10 mM solution in DMSO and used in
cultures at 1 μM. For PKG detection, a rabbit polyclonal human-PKG
antibody (Enzo) was used at a dilution of 1:1,000. The GFP-specific
mAb 11814460001 (Roche) was used at a dilution of 1:1,000, as was a
polyclonal rabbit anti-mCherry (ab167453; Abcam). A polyclonal rabbit
anti-SERA5 antibody was used at 1:2,000 (80). The anti-HSP70 antibody
(used at 1:1,000) was a kind gift of Dr Ellen Knuepfer, Francis
Crick Institute. Restriction enzymes were from New England BioLabs
and DNA ligations were performed with the Rapid DNA ligation kit
(Roche).
P. falciparum culture, transfection, and synchronisation
The B11 DiCre-expressing P. falciparum line (25) was maintained at
37°C in human erythrocytes in RPMI 1640 containing Albumax II
(Thermo Fisher Scientific) supplemented with 2 mM L-glutamine
and was used for all genetic modifications described. Cultures were
routinely microscopically examined using Giemsa-stained thin
blood films and mature schizonts were isolated by centrifugation
over 70% (vol/vol) isotonic Percoll (GE Healthcare, Life Sciences)
cushions. Highly synchronous ring-stage cultures were obtained by
allowing schizonts to invade fresh erythrocytes for 1–2 h under
shaking conditions followed by a second round of Percoll treatment
and treatment of the final pellet with 5% D-sorbitol to lyse residual
schizonts.
Transfections were performed as previously described (81). In
brief, ~108 Percoll-enriched schizonts were resuspended in 100 μl of
P3 primary cell solution (Lonza) containing 20 μg of Cas9 expression
plasmid and 60 μg of linearised donor plasmid. Program FP158 of
the Amaxa 4D Nucleofector X (Lonza) was used for electroporation.
Drug selection with 2.5 nM WR99210 started 24 h post transfection
for two cycles. Clonal lines were obtained by serial limiting dilution
in flat-bottomed 96-well plates (82). Single plaques were selected
and grown in the presence of 1 μM 5-fluorocytosine (5-FC, provided
as clinical grade Ancotyl) to select for Cas9 plasmid-free and
marker-free parasites.
For parasite genomic DNA extraction, the QIAGEN DNeasy
Blood and Tissue kit was used. Genotype analysis diagnostic
PCR was performed using Phusion polymerase (New England
BioLabs).
In all cases, DiCre activity was induced by transient RAP treat-
ment of highly synchronous early ring-stage parasites (2–3 h post
invasion) as previously described (10). Parasite samples for PCR
analysis of DiCre-mediated excision were collected 24 h after ini-
tiation of RAP treatment. Samples for Western blot analysis were
collected at 42 h post initiation of RAP treatment.
Plasmid construction and genotyping of transgenic lines
Sequences of the fragments used for all parasite modifications in
this study are provided in Supplemental Data 1.
Parasite line pfpkg_2loxwas created by replacing the third intron
of pfpkgwith 2loxPint (the P. falciparum 3D7 sera2 intron containing
loxN and lox2272 sequences, respectively). A DNA fragment was
commercially obtained comprising 447 bp upstream of intron 3 as
the 59 homology arm, the2loxPint module, and 436 bp downstream
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of intron 3 as the 39 homology arm (GeneArt, Thermo Fisher Sci-
entific). A single guide RNA targeting sequence TTTTAGGGTCA-
TACTTTTT was inserted into a previously described pDC2 plasmid
expressing Cas9, resulting in plasmid pDC2-2loxg (19). The repair
plasmid (pMX_2lox) was linearised with BgIII overnight and
transfected into parasites together with plasmid pDC2_2loxg. In-
tegration was confirmed by PCR, using primers exon1_For and
exon4_Rev and restriction digest of the PCR amplicon with AccI (a
full list of oligonucleotide primers used in this study is provided in
Table S1). Absence of the endogenous intron 3 was confirmed by
using primers exon1_For and intron3_Rev.
Construct pDC_loxnPKG:lox22mCherry was used to create line
pkg:wGFP-ckoR. and was based on vector pDC_mCherry_MCS (26).
The construct contains in tandem 1) a 59 homology arm of 399 bp
endogenous and 321 bp synthetic pfpkg sequence (obtained as a
gBlock from IDT) with the PbDT 39 UTR, 2) a fragment comprising
loxN, the 39 46 bp of the sera2 intron, a synthetic fragment of pfpkg
starting from exon 4 (the synthetic pfpkg cDNA cloned in vector
pTrcHis was used as a template) fused to the eGFP coding sequence
(56) and the pfhsp86 39UTR, and 3) the lox2272 sequence the 39 46 bp
of the sera2 intron, the mCherry coding sequence and the pfpkg
39UTR as the 39 homology arm. A single guide RNA–targeting se-
quence TTGGCCGGTTAATATATCA was cloned into the Cas9 vector,
generating plasmid pDC2_pkg. Vector pDC_loxnPKG:lox22mCherry
was linearised overnight with ScaI and transfected together with
the pDC2-pkg Cas9 plasmid into P. falciparum line pfpkg_2lox.
Correct 59 and 39 integration was verified by PCR using primers
K2_For/5int_Rev and PKGsynth_For/3int_Rev, respectively. Ab-
sence of the endogenous locus was confirmed using primers
exon1_For/PKGutr_Rev.
Line pkg:ckoR-mutGFP was generated using repair plasmid
pDC_loxNmCherry:lox22PKG. The relevant Ala substitutions were
made either by overlapping PCR (for substitutions of T202A, Y214A,
and S576A) using the synthetic pfpkg as a template, or were ob-
tained as a gBlock fragment (Y694A, T695A, S817A, and S819A) from
IDT. To create the plasmid, a synthetic fragment containing the loxN
sequence, the 39 46 bp of the sera2 intron, the mCherry gene, the
pfhsp86 39 UTR followed by lox2272, the 39 46 nucleotides of the
sera2 intron and the first 100 bp of a recodonised pfpkg exon 4 was
commercially obtained (GeneArt, Thermo Fisher Scientific). The
fragment was isolated by digest with HpaI/NcoI and cloned into a
plasmid containing the rest of the mutant synthetic pfpkg gene
fused to eGFP, followed by the pfpkg 39 UTR. This intermediate
vector was digested with HpaI/HindIII and the 59 homology arm
used in construct pDC_loxnPKG:lox22mCherry was cloned in,
resulting in the final vector. This was linearised with ScaI overnight
and transfected into line pfpkg_2lox with the pDC2-pkg Cas9 vector.
Correct integration was confirmed as described above for line pkg:
wGFP-ckoR.
For the pfpkg_3lox line, intron 3 of pfpkg was replaced with the
3loxPint module (the sera2 intron containing lox71, loxN, and
lox2272 sequences, respectively). A plasmid (pMX_3lox) containing
the module spanned by the same 59 and 39 homology arms as used
for line pfpkg_2lox was commercially obtained (GeneArt, Thermo
Fisher Scientific). Plasmid pMX_3lox was linearised overnight with
NcoI and transfected it together with plasmid pDC2_2loxg into P.
falciparum B11 schizonts. Integration and loss of the endogenous
pfpkg intron 3 was confirmed by PCR and restriction digest analysis
of the amplicon with AccI.
Construct pDC_3cKO was used to create line pkg:3cKO. Initially a
plasmid, pMX_3cKO-1, containing 1) the lox66 site followed by the 39
46 bp of the sera2 intron and the mTagBFP2 coding sequence with
the pfhrp2 39 UTR and 2) an loxN site followed by the 39 46 bp of the
sera2 intron and the eGFP coding sequence was commercially
obtained (GeneArt, Thermo Fisher Scientific). This plasmid was
linearised by restriction digest with BglII. A fragment containing the
hsp86 39 UTR, the lox2272, the 39 46 bp of the sera2 intron, mCherry
and the pfpkg 39UTR as the 39 homology arm was isolated from
plasmid pDC_loxnPKG:lox22mCherry and cloned into vector
pMX_3cKO-1, resulting in construct pDC_3cKOint. This intermediate
plasmid was digested with HpaI and NheI and a 3.2-kb fragment was
isolated and cloned into vector pDC_loxnPKG:lox22mCherry pre-
viously digested with the same enzymes, resulting in plasmid
pDC_3cKO. This was linearised overnight with ScaI and transfected
together with the pDC2_pkg plasmid into P. falciparum line
pfpkg_3lox.
Parasite growth assays
To determine parasite growth rates, synchronous ring-stage par-
asites at 0.1% parasitaemia and 2% haematocrit were dispensed in
triplicate into 12-well plates. Samples of 50 μl from each well were
collected at 0, 2, 4, and 6 d, stained with SYBR Green, and analysed
by flow cytometry on a BD FACSVerse using BD FACSuite software.
Data were analysed using FlowJo software.
Parasite egress assay
Parasite culture supernatants were prepared as previously de-
scribed (28). In brief, mature schizonts were isolated by Percoll
centrifugation and incubated for a further 3 h in complete medium
containing compound 2 (1 μM). After removal of the inhibitor,
schizonts were immediately resuspended in fresh serum-free RPMI
at 37°C to allow egress. Schizont pellets and culture supernatants at
t = 0 were collected as a control sample, whereas culture super-
natants were collected by centrifugation after 30 min.
Flow cytometry analysis
Parasites expressing eGFP or mCherry were quantified by flow
cytometry using a FACS Aria flow cytometer (BD Biosciences).
Samples were initially screened using forward and side scatter
parameters and gated for erythrocytes. For eGFP detection, a 488
nm Blue Laser was used with a 530/30 filter, whereas for mCherry, a
561 nm Yellow-Green Laser was used with a 610/20 filter. For
mTagBFP2 detection, the BD FACSVerse was used with a 450/50
filter.
Immunoblotting
Synchronised schizonts were isolated by Percoll gradient centri-
fugation and washed in RPMI 1640 without Albumax. Parasites were
extracted into a Triton X-100 buffer (20 mM Tris–HCl, pH 7.4, 150 mM
NaCl, 0.5 mM EDTA, and 1% vol/vol Triton X-100, supplemented with
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1× protease inhibitors [Roche]). Extracts were incubated on ice for
30 min then clarified by centrifugation at 12,000g for 15 min at 4°C.
Supernatants were mixed with SDS sample buffer containing DTT
and incubated for 5 min at 95°C before fractionation by SDS–PAGE
analysis on 4–15% Mini-PROTEAN TGX Stain-Free Protein Gels (Bio-
Rad). Transfer to nitrocellulose membranes and probing for Western
blot analysis was as described previously (38).
Time-lapse and live fluorescence microscopy
Viewing chambers were constructed as previously described (38).
Images were recorded on a Nikon Eclipse Ni light microscope fitted
with a Hamamatsu C11440 digital camera and Nikon N Plan Apo λ
63×/1.45NA oil immersion objective. For time-lapse video micros-
copy, differential inference contrast images were taken at 10-s
intervals over 30 min, whereas fluorescence (GFP, mTagBFP2, and
mCherry) images were taken every 2 min to prevent bleaching.
Time-lapse videos were analysed and annotated using Fiji (83).
Statistical analysis
All statistical analysis was carried out using GraphPad Prism 8.
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
201900626.
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